- Home
- OPAL vs CLYM Comparison
OPAL vs CLYM Comparison
Compare OPAL & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAL
- CLYM
- Stock Information
- Founded
- OPAL 1998
- CLYM 2018
- Country
- OPAL United States
- CLYM United States
- Employees
- OPAL N/A
- CLYM N/A
- Industry
- OPAL Natural Gas Distribution
- CLYM
- Sector
- OPAL Utilities
- CLYM
- Exchange
- OPAL Nasdaq
- CLYM NYSE
- Market Cap
- OPAL 88.1M
- CLYM 101.6M
- IPO Year
- OPAL N/A
- CLYM 2021
- Fundamental
- Price
- OPAL $1.84
- CLYM $1.22
- Analyst Decision
- OPAL Buy
- CLYM
- Analyst Count
- OPAL 5
- CLYM 0
- Target Price
- OPAL $5.70
- CLYM N/A
- AVG Volume (30 Days)
- OPAL 201.2K
- CLYM 172.8K
- Earning Date
- OPAL 03-13-2025
- CLYM 03-25-2025
- Dividend Yield
- OPAL N/A
- CLYM N/A
- EPS Growth
- OPAL N/A
- CLYM N/A
- EPS
- OPAL 0.02
- CLYM N/A
- Revenue
- OPAL $299,972,000.00
- CLYM N/A
- Revenue This Year
- OPAL $36.36
- CLYM N/A
- Revenue Next Year
- OPAL $24.61
- CLYM N/A
- P/E Ratio
- OPAL $88.25
- CLYM N/A
- Revenue Growth
- OPAL 17.13
- CLYM N/A
- 52 Week Low
- OPAL $1.74
- CLYM $1.20
- 52 Week High
- OPAL $5.18
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- OPAL 26.88
- CLYM N/A
- Support Level
- OPAL $1.87
- CLYM N/A
- Resistance Level
- OPAL $1.98
- CLYM N/A
- Average True Range (ATR)
- OPAL 0.13
- CLYM 0.00
- MACD
- OPAL 0.01
- CLYM 0.00
- Stochastic Oscillator
- OPAL 14.69
- CLYM 0.00
About OPAL OPAL Fuels Inc.
OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.